Breaking Through Barriers aims to help ensure that people with depression suffering from emotional and physical symptoms are diagnosed and treated as effectively as possible About- Breaking Through Barriers aims to help ensure that people with depression suffering from emotional and physical symptoms are diagnosed and treated as effectively as possible

Sponsors

Breaking Through Barriers is sponsored by the World Federation for Mental Health (WFMH), Eli Lilly and Company and Boehringer Ingelheim, and supported by patient organizations throughout Europe and Latin America.

World Federation for Mental Health

The World Federation for Mental Health was founded in 1948 to advance the prevention of mental and emotional disorders, the proper treatment and care of those with such disorders, and the promotion of mental health. The WFMH is an International non-governmental organization with members and contacts in 112 countries on six continents. The Federation’s organizational and individual membership includes mental health workers of all disciplines, people with depression, family members and caregivers and is governed by a volunteer board of directors from 17 countries, managed through a staffed secretariat. It is accredited in consultative status to the United Nations and its specialized agencies, and works closely with the World Health Organization.

Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations.  Headquartered in Indianapolis, Indiana, Lilly provides answers — through medicines and information — for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 143 affiliates in 47 countries and almost 37,500 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
For more information please visit www.boehringer-ingelheim.com.